RETENSION PHARMACEUTICALS: LEERINK PARTNERS, GUGGENHEIM SECURITIES, OPPENHEIMER & CO, TITAN PARTNERS ARE UNDERWRITERS TO IPO

Reuters · 1d ago

Please log in to view news